GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » Notes Receivable

Osteopore (ASX:OSX) Notes Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Osteopore Notes Receivable?

Osteopore's Notes Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Osteopore Notes Receivable Historical Data

The historical data trend for Osteopore's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore Notes Receivable Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial - - - - -

Osteopore Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Osteopore Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Osteopore Notes Receivable Related Terms

Thank you for viewing the detailed overview of Osteopore's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Osteopore (ASX:OSX) Business Description

Traded in Other Exchanges
N/A
Address
Ground Floor, 16 Ord Street, West Perth, Perth, WA, AUS, 6005
Osteopore Ltd is engaged in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore (ASX:OSX) Headlines

No Headlines